Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVI-VZV-001 vs Shingrix in Healthy Adults Aged 50 Years and Above
NCT07481604Phase 2Active, not recruiting
- Sponsor
- AriBio Lab
- Start
- Apr 2026
- Primary completion
- Jan 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CVI-VZV-001 in herpes zoster (HZ), sponsored by AriBio Lab. Started Apr 2026; status: active, not recruiting.
02
Drugs
CVI-VZV-001
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT07481604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07481604.